The LANDMARK trial reported the non-inferiority of the Myval transcatheter heart valve (THV) series compared with the contemporary standard THV series (Sapien and Evolut) for a 30-day composite endpoint in patients with severe aortic stenosis. This exploratory study compared the performance of the Myval THV series with the contemporary THV series using the win ratio analysis.
Akihiro Tobe, Niels van Royen, I Amat-Santos, M Hudec, M Bunc, Alexander Ijsselmuiden, José L. Pomar, Liesbeth Rosseel, Amr Gamal, Javaid Iqbal, Alan Soo, Scot Garg, Udita Chandra, Ashokkumar Thakkar, P Smits, Marie-Claude Morice, Yoshinobu Onuma, A Baumbach, Patrick W. Serruys
Osama Soliman, Elfatih A. Hasabo, Niels van Royen, Ignacio J. Amat‐Santos, Martin Hudec, Matjaž Bunc, Alexander Ijsselmuiden, Peep Laanmets, Daniel Unić, Béla Merkely, Renicus S. Hermanides, Mohamed Mouden, Vlasis Ninios, Marcin Protasiewicz, Benno J. Rensing, Pedro Martín, Fausto Feres, Manuel Almeida, Éric Van Belle, Axel Linke, Alfonso Ielasi, Matteo Montorfano, Mark Webster, Konstantinos Toutouzas,
Nikolaos Ktenopoulos, Maria Drakopoulou, Alfonso Ielasi, Vasileios F. Panoulas, Andreas Baumbach, Konstantinos Tsioufis, Patrick W. Serruys, Konstantinos Toutouzas, Anastasiοs Apostolos
Hideyuki Kawashima, Rutao Wang, Darren Mylotte, Dariusz Jagielak, Frederico De Marco, Alfonso Ielasi, Yoshinobu Onuma, Peter den Heijer, Christian Juhl Terkelsen, William Wijns, Patrick W. Serruys, Osama Soliman
Sandra Santos‐Martínez, Jonathan Halim, Alex F. Castro‐Mejía, Federico De Marco, Carlo Trani, Pedro Martín, Fabio Infusino, Marco Ancona, Raúl Moreno, Peter den Heijer, Luis Nombela‐Franco, Francesco Bedogni, Gennaro Sardella, Matteo Montorfano, Ana Revilla, José Raúl Delgado-Arana, Alejandro Barrero, Itzíar Gómez, Alexander Ijsselmuiden, Alfredo Redondo, Hipólito Gutiérrez, Ana Serrador, ,
Discussion(0)
No comments yet. Be the first to comment.